The sencond xiangya hospital,central south university

Slides:



Advertisements
Similar presentations
Non-Hodgkin’s Lymphoma
Advertisements

Non Hodgkin’s lymphoma
Hodgkin’s Disease (HD)
Chest lymphoma John-Henry Corbett Diagnostic Radiology University of Free Sate 04/2012.
HAEMATOLOGY MODULE: LYMPHOMA Adult Medical-Surgical Nursing.
Hodgkin lymphoma Histologic subtypes: - Nodular sclerosing - Mixed cellularity - Lymphocyte predominance -Lymphocyte depleted new category: - Lymphocyte.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 9 Disorders of White Blood Cells and Lymphoid Tissues.
LYMPHOMAS By DR : Ramy A. Samy.
By: Alexander Pilzer, Blakelee Ross, and Joshua Epley
Proposed WHO Classification of Lymphoid neoplasm
2010 Hematopoietic and Lymphoid Neoplasm Project Issues, Timing and Transformations.
Hodgkin Disease Definition: neoplastic disorder with development of specific infiltrate containing pathologic Reed-Sternberg cells. It usually arises in.
The lymphoreticular system is involved in the defence of the body against microorganisms and foreign substances – i.e. the immune response. Consists of.
Lymphoma Dr. Raid Jastania Dec By the end of this session you should be able to: –Discuss the basis of the classification of lymphomas –Know the.
Focusing on Hodgkin Disease
 B cell neoplasms  T/NK cell neoplasms  Hodgkin lymphoma (disease)
Nursing Care of the Child With Cancer. Neoplasia Cell growth in cancerous tissue proliferates in disorderly and chaotic ways Neoplasm- literally “new.
Lymphoma Nada Mohamed Ahmed , MD, MT (ASCP)i.
LYMPHOMA.
Timothy S. Fenske, MD April 5th, 2014
Lymphoma DR: Gehan Mohamed.
Non-Hodgkin’s lymphomas-definition and epidemiology
NRS 220 Alterations in Cellular Metabolism.  MDS is a group of disorders that is caused by the formation of abnormal cells in the bone marrow which can.
Lymphoma David Lee MD, FRCPC. Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of.
M. Mahmood Khan, MD Hematology-Oncology 12/5/03
Lymphoma. ALLMMCLLLymphomas Hematopoietic stem cell Neutrophils Eosinophils Basophils Monocytes Platelets Red cells Myeloid progenitor Myeloproliferative.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
(Relates to Chapter 31, “Nursing Management: Hematologic Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Treatment Planning Hodgkin Lymphoma.
Edward Camacho Mina 1061 MD4 WINDSOR UNIVERSITY HODGKIN LYMPHOMA.
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
Haematological Neoplasia:
L YMPHOMA FOR THE G ENERALIST Lee Berkowitz, MD. G OALS AND O BJECTIVES 1. Understand the importance of pathology and staging in the approach to management.
Treatment of Non- Hodgkin’s Lymphoma. Precursor B cell Lymphoblastic Leukemia Remission induction with combination therapy Consolidation phase: –High.
Bone Marrow Biopsy Focal involvement by small B-cell neoplasm without significant plasmacytic differentiation (CD3-, CD20+, PAX5+, kappa IHC-, lambda IHC-,
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
PTLD. PTLD: Post-transplant Lymphoproliferative Disorders.
Myeloproliferative Disorders (MPDs)
Associate Professor, & Consultant
Hodgkin lymphomas Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital Adapted from WHO Classification of Tumours of Haematopoietic.
Chronic lymphocytic leukemia What is C.L.L. ? a chronic disease one particular type of lymphocyte (B-cells) accumulates. not rapidly growing and proliferating.
Epidemiology Etiology Of Lymphoma Dr.Azarm Epidemiology In the United States, approximately 55,000 new cases of non-Hodgkin ’ s lymphoma are diagnosed.
Hematology and Hematologic Malignancies
LYMPHOMA Malignant transformation of cell in Lymphatic system There are about 600 Lymph Nodes in the body Spleen and gut also have lymphatic tissue.
Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.
APPROACH TO LYMPHOID MALIGNANCIES. Patient Evaluation of ALL Careful history and PE CBC Chemistry studies Bone marrow biopsy Lumbar puncture.
Neuroblastoma.
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
Non Hodgkin”s Lymphoma -- Histology appearance -- Cell of orgin -- Immunophenotype -- Molecular biology -- Clinical featres -- Prognosis -- Out-come of.
Educational Presentation
Hodgkin’s Lymphoma Hodgkin’s Lymphoma Disease in which malignant (cancer) cells form in the lymph system Type of cancer that develops in.
MLAB Hematology Keri Brophy-Martinez
(A) the hematopoietic stem cell transplanted (HSCT) recipients only (B) both autologous and allogeneic transplanted recipients (C) both solid organ and.
Chapter 11 Lymphatic System Disorders Mitzy D. Flores, MSN, RN.
Asymptomatic lymphadenopathy Mediastinal mass Systemic symptoms Fever, Pruritus Other nonspecific symptoms and paraneoplastic syndromes Intra-abdominal.
Non-Hodgkin Lymphoma March 13, 2013 Suzanne R. Fanning, DO Greenville Health System.
Cellular origin of lymphoma
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
NON-HODGKIN’S LYMPHOMA
Lymphoma David Lee MD, FRCPC.
Cellular origin of lymphoma
Non-Hodgkin’s Lymphoma
Dr.Hussein Alatabi MBChB,DCH,FICMS,CABP
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
MLAB Hematology Keri Brophy-Martinez
Lymphomas: Part II.
Leukemia case #9 Hello lovely girl وداد ابو رمضان حليمة نوفل
Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)
Lymphomas.
Presentation transcript:

The sencond xiangya hospital,central south university Lymphoma The sencond xiangya hospital,central south university Pei minfei

Definition Neoplasm of the immune system(B-or T-cell), Neoplasm of the lymphoid tissue,usually arising in lymph nodes Hodgkin’s disease(HD)----Reed-Stemberg cell no Hodgkin lymphomas(NHL)---B-or T-cell at different stages of maturation (highly heterogeneous)

Epidemiology 1.The incidence of lymphoma,especially NHL,has been increasing steadily 2.More common in men than women(1.39 vs 0.84 per 100,000, in China),age distribution:20-40 years 3.NHL is more often than HD 4.The incidence of T-cell lymphoma is higher

Etiology 1.Infectious agents:Epstein-barr vinus(EBV); HTLV-1; Helicobacter pylori(Hp)(MALT- lymphoma); Hepatitis C virus(HCV) 2.Chemicals: pesticides,benzene,hair dyes 3.Immunosuppression: AIDS; rheumatoid disease 4.Genetic susceptibility 5.Radiation

Pathobiology and Classification 1.Basic pathobiologic features Proliferation and infiltration of the malignant monoclonal lymphoil cell (2)The normal constructure of the lymph nodes or lymphoid tissue is destroied completely or partially 2.Four subgroups of HD lymphocyte predominant; mixed cellularity; nodular sclerosing; lymphocyte depleted

Clinical manifestations 3.Classification of NHL (1)Working formulation(low、intermediate、high grade) (2)REAL classification(B-cell,T-cell and NK cell neoplasms,HD; indolent,aggressive,very aggressive) Clinical manifestations 1.Painless,progressive lymph node enlargement regions:cervical,supraclavicular,axillary,inguinal, epitrochlear nature:nontender, firm, rubbery, bulky rare phenomena: wax and wane,lymph node pain after ingestion of alcoholic beverages

2.Obstruction and/or infiltration symptoms(extra- nodal involvement) 3.Systemic symtoms: fever,night sweats,weight loss(B symptoms); fatigue,pruritus,cytopenia 4.Difference between HD and NHL The main difference is that of the pathobiology. The other difference appears in age,primary regions,spread methods,extranodal involvement, prognosis et al.

Laboratory examination 1.Complete blood counts 2.Blood chemistries:ESR,LDH,-MG,AKP,Ig, EBV-Ab,Coombs’test 3.Bone marrow aspiration and biopsy 4.Imaging studies:X-ray,ultrasonography,CT,MRI 5.Biopsy of the enlarged lymph node and/or suspected tissue 6.Others:lumbar pucture,abdominocentesis, thoracocentesis,endoscope,laprotomy

Dignosis and Diffrential Dignosis 1.Dignosis is established on the pathomorphology and immunopathology 2.Diffrential Dignosis (1)lymph node enlargment (2)fever of unknown origion (3)benign or malignant diseases of organs or tissue

Staging—Ann Arbor Staging Classification Ⅰ and Ⅱ:on the same side of the diaphragm Ⅲ: on the both sides of the diaphragm Ⅳ: diffuse or disseminated involvement group A group B Ⅰ

Treatment 1.Radiotherapy: (1)Radiotherapy fields: mantle—cervical,supraclavicular, infraclavicular,axillary,mediastinal,hilar nodes; inverted Y— paraaortic plus pelvic; subtotal nodal irradiation(SNI)= mantle plus paraaortic; total nodal irradiation(TNI)= mantle plus inverted Y; limited field irradiation (2)Indication: the patients of HD at ⅠA-ⅡA stages; some patients with low-grade NHL; limited field radiation for some patients with lymphomas

2.Chemotherapy (1)Indication: the patients who are not suitable to radiotherapy (2)Regiems: HD—ABVD,MOPP; NHL—CHOP 3.Immunotherapy a-Interferon; Anti-idiotype antibodies(such as Rituximab); radioimmunotherapy; immunotoxin 4.Surgery 5.HSCT autologous bone marrow transplantation allogenic blood stem cell

Thanks!